250 related articles for article (PubMed ID: 28865890)
1. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
[TBL] [Abstract][Full Text] [Related]
4. Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation.
Nilsson B; Goetze JP; Chen X; Pehrson S; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(8):843-50. PubMed ID: 19929271
[TBL] [Abstract][Full Text] [Related]
5. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.
Dixen U; Ravn L; Soeby-Rasmussen C; Paulsen AW; Parner J; Frandsen E; Jensen GB
Cardiology; 2007; 108(1):35-9. PubMed ID: 16968988
[TBL] [Abstract][Full Text] [Related]
6. Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.
Latini R; Masson S; Pirelli S; Barlera S; Pulitano G; Carbonieri E; Gulizia M; Vago T; Favero C; Zdunek D; Struck J; Staszewsky L; Maggioni AP; Franzosi MG; Disertori M;
J Intern Med; 2011 Feb; 269(2):160-71. PubMed ID: 20964739
[TBL] [Abstract][Full Text] [Related]
7. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
8. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
9. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion.
Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P
Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
[TBL] [Abstract][Full Text] [Related]
11. Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation.
Hwang HJ; Son JW; Nam BH; Joung B; Lee B; Kim JB; Lee MH; Jang Y; Chung N; Shim WH; Cho SY; Kim SS
Clin Res Cardiol; 2009 Apr; 98(4):213-8. PubMed ID: 19229464
[TBL] [Abstract][Full Text] [Related]
12. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation.
Lan X; Su L; Ling Z; Liu Z; Wu J; Yang X; Zrenner B; Yin Y
Eur J Clin Invest; 2009 Aug; 39(8):657-63. PubMed ID: 19490069
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
[TBL] [Abstract][Full Text] [Related]
14. Plasma NT-proANP in patients with persistent atrial fibrillation who underwent successful cardioversion.
Bartkowiak R; Wozakowska-Kapłon B; Janiszewska G
Kardiol Pol; 2010 Jan; 68(1):48-54. PubMed ID: 20131188
[TBL] [Abstract][Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
16. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of N-terminal pro-B-type natriuretic peptide measurement in the follow up of pulmonary vein ablation].
Arana-Rueda E; Pedrote A; García-Riesco L; Arce-León Á; Guerrero-Márquez F; Rodríguez-Rodríguez J
Med Clin (Barc); 2015 Sep; 145(6):248-50. PubMed ID: 25561181
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.
Solheim E; Off MK; Hoff PI; De Bortoli A; Schuster P; Ohm OJ; Chen J
J Interv Card Electrophysiol; 2012 Aug; 34(2):129-36. PubMed ID: 21993599
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-atrial natriuretic peptide as a biochemical marker of long-term interventional success after radiofrequency catheter ablation of paroxysmal supraventricular tachyarrhythmias.
Brueckmann M; Bertsch T; Hoffmann U; Lang S; Kaden JJ; Wolpert C; Huhle G; Borggrefe M; Haase KK
Clin Chem Lab Med; 2004; 42(8):896-902. PubMed ID: 15387439
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
